- view as grid
- view as list
This fact sheet provides current information about state AIDS Drug Assistance Programs (ADAPs), which provide HIV medications to low-income people with HIV/AIDS who have limited or no prescription drug coverage.
This updated fact sheet highlights the impact of HIV/AIDS on women in the United States, providing current data and trends over time.
Health Affairs Blog: The ACA And People With HIV: The ACA’s Impact And The Implications Of State Choices
A Health Affairs blog post by Jennifer Kates and Rachel Garfield examines the impact of the Affordable Care Act (ACA) on people with HIV/AIDS.
This analysis examines state Medicaid coverage of routine HIV screening and finds that currently, more than two thirds of states cover routine screening under their Medicaid programs. The analysis includes a breakdown of which states cover routine screening and which states only cover medically necessary HIV screening.
Health Care Access and Coverage for the Lesbian, Gay, Bisexual, and Transgender (LGBT) Community in the United States: Opportunities and Challenges in a New Era
This Policy Insight looks at the challenges and questions surrounding recent policy changes that are expected to increase health insurance coverage and access to care for lesbian, gay, bisexual and transgender (LGBT) individuals and their families, including the impact of the Affordable Care Act (ACA) and the Supreme Court’s DOMA decision.
This analysis provides the first national estimates of the expected impact of the Affordable Care Act’s (ACA) coverage expansions on people with HIV. The brief finds that close to 70,000 uninsured people with HIV who are in care could gain new coverage, including 47,000 through Medicaid were all states to expand their Medicaid coverage.
Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold?
There are numerous aspects of the Affordable Care Act that will be important for people with HIV in the U.S., — however, it is unlikely that these changes will address all the needs of people with HIV. The Ryan White HIV/AIDS Program will thus remain crucial for the provision of adequate health care to HIV-infected individuals, but it will need to change. Changes in the Ryan White Program’s role will depend largely on state decisions on Medicaid expansion and health care marketplaces. This article, published in the September/October issue of Topics in Antiviral Medicine, summarizes a presentation by Jennifer Kates of the Kaiser Family Foundation at the IAS–USA continuing education program held in New York, New York, in April 2013.
In March 2013, the Kaiser Family Foundation convened key HIV/AIDS stakeholders from a variety of backgrounds to explore opportunities for maximizing the beneficial impact of the Affordable Care Act (ACA) for people living with HIV and examine strategies to help them navigate the transition to new health coverage. This report summarizes the information shared and key issues discussed at the meeting.